◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items
悦康药业 — Financial Statements
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
+Revenue 2.4B 3.8B 4.2B 4.5B 5.0B 4.3B 4.3B 4.0B 2.7B
Revenue Growth % -35.3% -9.9% -7.6% -8.5% 14.5% 1.2% 7.7% 47.5% --
Total Revenue 2.4B 3.8B 4.2B 4.5B 5.0B 4.3B 4.3B 4.0B 2.7B
Cost Of Revenue 1.2B 1.6B 1.6B 1.6B 1.5B 1.5B 1.7B 1.6B 1.5B
+Gross Profit 1.2B 2.2B 2.6B 2.9B 3.4B 2.9B 2.6B 2.4B 1.2B
Gross Margin % 50.2% 57.8% 62.7% 64.6% 69.3% 66.0% 60.9% 60.2% 43.0%
Total Operating Cost 2.7B 3.7B 4.0B 4.3B 4.4B 3.9B 4.0B 3.7B 2.5B
Selling Expenses 704.0M 1.3B 1.8B 2.0B 2.3B 2.0B 1.9B 1.7B 652.0M
Admin Expenses 267.0M 240.0M 230.0M 245.0M 232.0M 173.0M 181.0M 164.0M 161.0M
Rd Expenses 441.0M 374.0M 352.0M 344.0M 200.0M 128.0M 126.0M 98.1M 81.7M
Finance Expenses 13.3M 5.0M -10.3M -32.7M -33.1M 39.6M 38.2M 33.0M 83.2M
+Operating Income -234.0M 159.0M 232.0M 358.0M 637.0M 492.0M 328.0M 323.0M 189.0M
Operating Margin % -9.6% 4.2% 5.5% 7.9% 12.8% 11.3% 7.6% 8.1% 7.0%
Non Operating Income 1.6M 4.0M 2.0M 4.9M 1.9M 6.7M 6.6M 6.6M 13.0M
Non Operating Expenses 4.2M 10.7M 10.5M 13.4M 9.4M 3.7M 2.9M 5.1M 2.9M
Investment Income 3.5M 442,400 -320,700 1.1M 4.0M -- 106,800 309,200 5.5M
Fair Value Change Income 6.0M 2.3M -686,900 2.9M -- -- -- -- --
Asset Disposal Income 924,100 -383,500 1.0M 41,000 10,400 -- 1,600 40,100 -359,400
Asset Impairment Loss 41.5M 101.0M 62.4M 52.0M 41.0M 21.7M 21.9M 21.6M -26.2M
Other Income 29.1M 33.5M 44.4M 81.2M 44.7M 51.5M 19.3M 16.1M 12.3M
Income Before Tax -237.0M 152.0M 223.0M 350.0M 629.0M 495.0M 332.0M 325.0M 199.0M
Income Tax 37.8M 31.1M 35.8M 10.6M 85.5M 51.5M 44.0M 56.0M 38.2M
+Net Income -275.0M 121.0M 187.0M 339.0M 544.0M 444.0M 288.0M 269.0M 161.0M
Net Margin % -11.2% 3.2% 4.5% 7.5% 11.0% 10.2% 6.7% 6.8% 6.0%
Net Income Attributable -262.0M 124.0M 185.0M 335.0M 545.0M 442.0M 285.0M 268.0M 162.0M
Minority Interest -12.4M -2.5M 2.7M 3.7M -1.6M 1.5M 2.3M 949,800 -686,900
Eps Basic -0.59 0.28 0.41 0.74 1.21 1.23 0.79 -- --
Eps Diluted -0.59 0.28 0.41 0.74 1.21 1.23 0.79 -- --
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash And Equivalents 1.0B 1.3B 1.5B 1.7B 2.4B 2.5B 395.0M 302.0M 792.0M
Trading Financial Assets 398.0M 160.0M -- -- -- -- -- -- --
Accounts Receivable 487.0M 612.0M 894.0M 1.2B 817.0M 565.0M 717.0M 645.0M 327.0M
Notes Receivable 49.4M 104.0M 102.0M 55.9M 49.5M 49.8M 98.0M 131.0M 46.3M
Notes And Accounts Receivable 536.0M 716.0M 996.0M 1.3B 866.0M 614.0M 815.0M 776.0M 373.0M
Prepayments 39.1M 52.7M 73.0M 59.7M 29.7M 14.7M 15.2M 19.7M 15.3M
Inventory 465.0M 757.0M 728.0M 738.0M 632.0M 627.0M 557.0M 700.0M 498.0M
Total Current Assets 2.6B 3.2B 3.4B 3.9B 4.1B 3.9B 1.9B 1.9B 2.0B
Fixed Assets -- 1.4B 1.5B 1.2B 1.2B 1.2B 1.2B 1.2B 1.1B
Fixed Assets Total 1.3B 1.4B 1.5B 1.2B 1.2B 1.2B 1.2B 1.2B 1.1B
Construction In Progress -- 540.0M 471.0M 458.0M 74.9M 108.0M 83.4M 112.0M 170.0M
Construction In Progress Total 689.0M 540.0M 471.0M 458.0M 74.9M 108.0M 83.4M 112.0M 170.0M
Intangible Assets 164.0M 175.0M 174.0M 175.0M 181.0M 134.0M 136.0M 147.0M 148.0M
Long Term Deferred Expenses 4.3M 8.2M 10.1M 822,400 1.7M 4.3M 4.5M 6.4M 6.3M
Total Non Current Assets 2.6B 2.6B 2.5B 2.1B 1.7B 1.6B 1.6B 1.6B 1.5B
Total Assets 5.2B 5.7B 5.9B 6.0B 5.7B 5.5B 3.5B 3.4B 3.5B
Short Term Borrowings 55.2M 113.0M 352.0M 228.0M 9.0M 160.0M 437.0M 300.0M 536.0M
Accounts Payable 474.0M 431.0M 506.0M 497.0M 512.0M 524.0M 591.0M 764.0M 842.0M
Advance Receipts -- -- -- -- -- 772,200 41.5M 54.4M 55.0M
Contract Liabilities 21.8M 44.5M 29.7M 57.1M 29.7M 62.8M -- -- --
Total Current Liabilities 1.7B 1.5B 2.1B 1.9B 1.7B 1.8B 2.2B 2.4B 2.6B
Long Term Borrowings 77.5M 517.0M 54.6M -- -- -- -- -- 110.0M
Total Non Current Liabilities 212.0M 648.0M 177.0M 112.0M 117.0M 91.9M 141.0M 160.0M 238.0M
Total Liabilities 1.9B 2.2B 2.3B 2.0B 1.8B 1.9B 2.3B 2.6B 2.8B
Paid In Capital 450.0M 450.0M 450.0M 450.0M 450.0M 450.0M 360.0M 142.0M 142.0M
Capital Reserve 2.6B 2.6B 2.6B 2.7B 2.6B 2.6B 718.0M 853.0M 991.0M
Surplus Reserve 199.0M 193.0M 162.0M 137.0M 98.0M 47.0M 24.3M 75.9M 75.9M
Retained Earnings 121.0M 390.0M 385.0M 721.0M 731.0M 439.0M 19.4M -235.0M -503.0M
Minority Equity -5.0M 7.3M 9.8M 8.1M 3.4M 5.0M 3.5M 7.2M 6.3M
Equity Attributable 3.3B 3.6B 3.6B 4.0B 3.9B 3.6B 1.1B 836.0M 706.0M
Total Equity 3.3B 3.6B 3.6B 4.0B 3.9B 3.6B 1.1B 843.0M 712.0M
Line ItemFY 2025Dec 31, 2025FY 2024Dec 31, 2024FY 2023Dec 31, 2023FY 2022Dec 31, 2022FY 2021Dec 31, 2021FY 2020Dec 31, 2020FY 2019Dec 31, 2019FY 2018Dec 31, 2018FY 2017Dec 31, 2017
Cash From Sales 2.8B 4.3B 4.7B 4.5B 5.1B 4.9B 4.3B 3.8B 2.6B
Tax Refunds Received 34.9M 25.8M 34.9M 25.5M 4.6M 15.6M 6.2M 5.4M 2.9M
Total Operating Cash Inflow 3.1B 4.4B 4.9B 4.6B 5.2B 5.0B 4.4B 4.1B 2.7B
Cash Paid For Goods 786.0M 1.2B 1.4B 1.6B 1.4B 1.5B 1.3B 1.7B 1.4B
Cash Paid To Employees 430.0M 456.0M 448.0M 434.0M 318.0M 267.0M 270.0M 261.0M 229.0M
Taxes Paid 223.0M 393.0M 393.0M 512.0M 517.0M 418.0M 454.0M 397.0M 224.0M
Total Operating Cash Outflow 2.7B 3.9B 4.1B 4.7B 4.7B 4.3B 4.1B 3.9B 2.5B
Operating Cash Flow 340.0M 438.0M 785.0M -121.0M 515.0M 698.0M 325.0M 193.0M 215.0M
Total Investing Cash Inflow 634.0M 849,000 10.9M 101.0M 386.0M -- 139,700 309.0M 1.4B
Total Investing Cash Outflow 1.1B 547.0M 513.0M 658.0M 587.0M 191.0M 180.0M 333.0M 912.0M
Investing Cash Flow -470.0M -546.0M -502.0M -557.0M -201.0M -191.0M -180.0M -24.5M 472.0M
Cash From Borrowings 123.0M 649.0M 387.0M 228.0M 9.0M 161.0M 446.0M 339.0M 1.2B
Dividends And Interest Paid 23.2M 111.0M 505.0M 308.0M 205.0M 22.2M 25.8M 31.1M 392.0M
Debt Repayments 203.0M 510.0M 248.0M 9.0M 160.0M 437.0M 420.0M 636.0M 2.2B
Total Financing Cash Inflow 123.0M 649.0M 387.0M 228.0M 9.0M 2.2B 530.0M 438.0M 2.5B
Total Financing Cash Outflow 235.0M 677.0M 819.0M 330.0M 417.0M 559.0M 538.0M 859.0M 3.0B
Financing Cash Flow -112.0M -28.5M -432.0M -102.0M -408.0M 1.6B -7.7M -421.0M -502.0M
Net Change In Cash -241.0M -136.0M -145.0M -773.0M -94.8M 2.1B 138.0M -252.0M 185.0M
Ending Cash Balance 997.0M 1.2B 1.4B 1.5B 2.3B 2.4B 245.0M 107.0M 359.0M
Capex 135.0M 359.0M 497.0M 548.0M 200.0M 127.0M 148.0M 174.0M 105.0M
NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...